H2N2V1, PubMed, Checkpoint, bibRecord, 000100

Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.

Identifieur interne : 000100 ( PubMed/Checkpoint ); précédent : 000099; suivant : 000101

Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.

Auteurs : Arkadiusz Wyrzucki [Suisse] ; Cyrille Dreyfus [États-Unis] ; Ines Kohler [Suisse] ; Marco Steck [Suisse] ; Ian A. Wilson [Suisse] ; Lars Hangartner [Suisse]

Source :

Journal of virology [ 1098-5514 ] ; 2014.

RBID : pubmed:24719426

Descripteurs français

English descriptors

KwdEn :
- Amino Acid Sequence, Animals, Antibodies, Viral (genetics), Antibodies, Viral (immunology), Conserved Sequence, Epitope Mapping, Epitopes (chemistry), Epitopes (genetics), Epitopes (immunology), Hemagglutinin Glycoproteins, Influenza Virus (chemistry), Hemagglutinin Glycoproteins, Influenza Virus (genetics), Hemagglutinin Glycoproteins, Influenza Virus (immunology), Humans, Immunoglobulin Heavy Chains (genetics), Immunoglobulin Heavy Chains (immunology), Influenza A Virus, H1N1 Subtype (chemistry), Influenza A Virus, H1N1 Subtype (genetics), Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H2N2 Subtype (chemistry), Influenza A Virus, H2N2 Subtype (genetics), Influenza A Virus, H2N2 Subtype (immunology), Influenza A virus (chemistry), Influenza A virus (genetics), Influenza A virus (immunology), Influenza, Human (immunology), Influenza, Human (virology), Mice, Models, Molecular.
MESH :
- chemical , chemistry : Epitopes, Hemagglutinin Glycoproteins, Influenza Virus.
- chemical , genetics : Antibodies, Viral, Epitopes, Hemagglutinin Glycoproteins, Influenza Virus, Immunoglobulin Heavy Chains.
- chemical , immunology : Antibodies, Viral, Epitopes, Hemagglutinin Glycoproteins, Influenza Virus, Immunoglobulin Heavy Chains.
- chemistry : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H2N2 Subtype, Influenza A virus.
- genetics : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H2N2 Subtype, Influenza A virus.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H2N2 Subtype, Influenza A virus, Influenza, Human.
- virology : Influenza, Human.
- Amino Acid Sequence, Animals, Conserved Sequence, Epitope Mapping, Humans, Mice, Models, Molecular.

Abstract

A human monoclonal heterosubtypic antibody, MAb 3.1, with its heavy chain encoded by VH3-30, was isolated using phage display with immobilized hemagglutinin (HA) from influenza virus A/Japan/305/1957(H2N2) as the target. Antibody 3.1 potently neutralizes influenza viruses from the H1a clade (i.e., H1, H2, H5, H6) but has little neutralizing activity against the H1b clade. Its crystal structure in complex with HA from a pandemic H1N1 influenza virus, A/South Carolina/1/1918(H1N1), revealed that like other heterosubtypic anti-influenza virus antibodies, MAb 3.1 contacts a hydrophobic groove in the HA stem, primarily using its heavy chain. However, in contrast to the closely related monoclonal antibody (Mab) FI6 that relies heavily on HCDR3 for binding, MAb 3.1 utilizes residues from HCDR1, HCDR3, and framework region 3 (FR3). Interestingly, HCDR1 of MAb 3.1 adopts an α-helical conformation and engages in hydrophobic interactions with the HA very similar to those of the de novo in silico-designed and affinity-matured synthetic protein HB36.3. These findings improve our understanding of the molecular requirements for binding to the conserved epitope in the stem of the HA protein and, therefore, aid the development of more universal influenza vaccines targeting these epitopes.

DOI: 10.1128/JVI.00178-14
PubMed: 24719426

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000102
to stream PubMed, to step Curation: 000102

Links to Exploration step

pubmed:24719426

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.</title>
<author><name sortKey="Wyrzucki, Arkadiusz" sort="Wyrzucki, Arkadiusz" uniqKey="Wyrzucki A" first="Arkadiusz" last="Wyrzucki">Arkadiusz Wyrzucki</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Dreyfus, Cyrille" sort="Dreyfus, Cyrille" uniqKey="Dreyfus C" first="Cyrille" last="Dreyfus">Cyrille Dreyfus</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kohler, Ines" sort="Kohler, Ines" uniqKey="Kohler I" first="Ines" last="Kohler">Ines Kohler</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Steck, Marco" sort="Steck, Marco" uniqKey="Steck M" first="Marco" last="Steck">Marco Steck</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Wilson, Ian A" sort="Wilson, Ian A" uniqKey="Wilson I" first="Ian A" last="Wilson">Ian A. Wilson</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA hangartner.lars@virology.uzh.ch wilson@scripps.edu.</nlm:affiliation>
<country wicri:rule="url">Suisse</country>
<wicri:regionArea>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California</wicri:regionArea>
<wicri:noRegion>California</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hangartner, Lars" sort="Hangartner, Lars" uniqKey="Hangartner L" first="Lars" last="Hangartner">Lars Hangartner</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland hangartner.lars@virology.uzh.ch wilson@scripps.edu.</nlm:affiliation>
<country wicri:rule="url">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24719426</idno>
<idno type="pmid">24719426</idno>
<idno type="doi">10.1128/JVI.00178-14</idno>
<idno type="wicri:Area/PubMed/Corpus">000102</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000102</idno>
<idno type="wicri:Area/PubMed/Curation">000102</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000102</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000100</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000100</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.</title>
<author><name sortKey="Wyrzucki, Arkadiusz" sort="Wyrzucki, Arkadiusz" uniqKey="Wyrzucki A" first="Arkadiusz" last="Wyrzucki">Arkadiusz Wyrzucki</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Dreyfus, Cyrille" sort="Dreyfus, Cyrille" uniqKey="Dreyfus C" first="Cyrille" last="Dreyfus">Cyrille Dreyfus</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kohler, Ines" sort="Kohler, Ines" uniqKey="Kohler I" first="Ines" last="Kohler">Ines Kohler</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Steck, Marco" sort="Steck, Marco" uniqKey="Steck M" first="Marco" last="Steck">Marco Steck</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
<author><name sortKey="Wilson, Ian A" sort="Wilson, Ian A" uniqKey="Wilson I" first="Ian A" last="Wilson">Ian A. Wilson</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA hangartner.lars@virology.uzh.ch wilson@scripps.edu.</nlm:affiliation>
<country wicri:rule="url">Suisse</country>
<wicri:regionArea>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California</wicri:regionArea>
<wicri:noRegion>California</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hangartner, Lars" sort="Hangartner, Lars" uniqKey="Hangartner L" first="Lars" last="Hangartner">Lars Hangartner</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland hangartner.lars@virology.uzh.ch wilson@scripps.edu.</nlm:affiliation>
<country wicri:rule="url">Suisse</country>
<wicri:regionArea>Institute of Medical Virology, University of Zurich, Zürich</wicri:regionArea>
<placeName><settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
<orgName type="university">Université de Zurich</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Antibodies, Viral (genetics)</term>
<term>Antibodies, Viral (immunology)</term>
<term>Conserved Sequence</term>
<term>Epitope Mapping</term>
<term>Epitopes (chemistry)</term>
<term>Epitopes (genetics)</term>
<term>Epitopes (immunology)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (chemistry)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (genetics)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (immunology)</term>
<term>Humans</term>
<term>Immunoglobulin Heavy Chains (genetics)</term>
<term>Immunoglobulin Heavy Chains (immunology)</term>
<term>Influenza A Virus, H1N1 Subtype (chemistry)</term>
<term>Influenza A Virus, H1N1 Subtype (genetics)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H2N2 Subtype (chemistry)</term>
<term>Influenza A Virus, H2N2 Subtype (genetics)</term>
<term>Influenza A Virus, H2N2 Subtype (immunology)</term>
<term>Influenza A virus (chemistry)</term>
<term>Influenza A virus (genetics)</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (virology)</term>
<term>Mice</term>
<term>Models, Molecular</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Anticorps antiviraux (génétique)</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Cartographie épitopique</term>
<term>Chaines lourdes des immunoglobulines (génétique)</term>
<term>Chaines lourdes des immunoglobulines (immunologie)</term>
<term>Glycoprotéine hémagglutinine du virus influenza ()</term>
<term>Glycoprotéine hémagglutinine du virus influenza (génétique)</term>
<term>Glycoprotéine hémagglutinine du virus influenza (immunologie)</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains</term>
<term>Modèles moléculaires</term>
<term>Souris</term>
<term>Sous-type H1N1 du virus de la grippe A ()</term>
<term>Sous-type H1N1 du virus de la grippe A (génétique)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H2N2 du virus de la grippe A ()</term>
<term>Sous-type H2N2 du virus de la grippe A (génétique)</term>
<term>Sous-type H2N2 du virus de la grippe A (immunologie)</term>
<term>Séquence conservée</term>
<term>Séquence d'acides aminés</term>
<term>Virus de la grippe A ()</term>
<term>Virus de la grippe A (génétique)</term>
<term>Virus de la grippe A (immunologie)</term>
<term>Épitopes ()</term>
<term>Épitopes (génétique)</term>
<term>Épitopes (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Epitopes</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antibodies, Viral</term>
<term>Epitopes</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>Immunoglobulin Heavy Chains</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
<term>Epitopes</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
<term>Immunoglobulin Heavy Chains</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Chaines lourdes des immunoglobulines</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Virus de la grippe A</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Chaines lourdes des immunoglobulines</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Grippe humaine</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Virus de la grippe A</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza A virus</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Conserved Sequence</term>
<term>Epitope Mapping</term>
<term>Humans</term>
<term>Mice</term>
<term>Models, Molecular</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Cartographie épitopique</term>
<term>Glycoprotéine hémagglutinine du virus influenza</term>
<term>Humains</term>
<term>Modèles moléculaires</term>
<term>Souris</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Séquence conservée</term>
<term>Séquence d'acides aminés</term>
<term>Virus de la grippe A</term>
<term>Épitopes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A human monoclonal heterosubtypic antibody, MAb 3.1, with its heavy chain encoded by VH3-30, was isolated using phage display with immobilized hemagglutinin (HA) from influenza virus A/Japan/305/1957(H2N2) as the target. Antibody 3.1 potently neutralizes influenza viruses from the H1a clade (i.e., H1, H2, H5, H6) but has little neutralizing activity against the H1b clade. Its crystal structure in complex with HA from a pandemic H1N1 influenza virus, A/South Carolina/1/1918(H1N1), revealed that like other heterosubtypic anti-influenza virus antibodies, MAb 3.1 contacts a hydrophobic groove in the HA stem, primarily using its heavy chain. However, in contrast to the closely related monoclonal antibody (Mab) FI6 that relies heavily on HCDR3 for binding, MAb 3.1 utilizes residues from HCDR1, HCDR3, and framework region 3 (FR3). Interestingly, HCDR1 of MAb 3.1 adopts an α-helical conformation and engages in hydrophobic interactions with the HA very similar to those of the de novo in silico-designed and affinity-matured synthetic protein HB36.3. These findings improve our understanding of the molecular requirements for binding to the conserved epitope in the stem of the HA protein and, therefore, aid the development of more universal influenza vaccines targeting these epitopes.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24719426</PMID>
<DateCompleted><Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>88</Volume>
<Issue>12</Issue>
<PubDate><Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.</ArticleTitle>
<Pagination><MedlinePgn>7083-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00178-14</ELocationID>
<Abstract><AbstractText Label="UNLABELLED">A human monoclonal heterosubtypic antibody, MAb 3.1, with its heavy chain encoded by VH3-30, was isolated using phage display with immobilized hemagglutinin (HA) from influenza virus A/Japan/305/1957(H2N2) as the target. Antibody 3.1 potently neutralizes influenza viruses from the H1a clade (i.e., H1, H2, H5, H6) but has little neutralizing activity against the H1b clade. Its crystal structure in complex with HA from a pandemic H1N1 influenza virus, A/South Carolina/1/1918(H1N1), revealed that like other heterosubtypic anti-influenza virus antibodies, MAb 3.1 contacts a hydrophobic groove in the HA stem, primarily using its heavy chain. However, in contrast to the closely related monoclonal antibody (Mab) FI6 that relies heavily on HCDR3 for binding, MAb 3.1 utilizes residues from HCDR1, HCDR3, and framework region 3 (FR3). Interestingly, HCDR1 of MAb 3.1 adopts an α-helical conformation and engages in hydrophobic interactions with the HA very similar to those of the de novo in silico-designed and affinity-matured synthetic protein HB36.3. These findings improve our understanding of the molecular requirements for binding to the conserved epitope in the stem of the HA protein and, therefore, aid the development of more universal influenza vaccines targeting these epitopes.</AbstractText>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Influenza viruses rapidly evade preexisting immunity by constantly altering the immunodominant neutralizing antibody epitopes (antigenic drift) or by acquiring new envelope serotypes (antigenic shift). As a consequence, the majority of antibodies elicited by immunization or infection protect only against the immunizing or closely related strains. Here, we describe a novel monoclonal antibody that recognizes the conserved heterosubtypic epitope in the stem of influenza A virus hemagglutinin. This antibody, referred to as MAb 3.1, recognizes its epitope in a manner that resembles recognition of a similar epitope by the de novo in silico-designed and affinity-matured synthetic protein HB36.3. Thus, besides providing novel insights into the molecular interactions between heterosubtypic antibodies and influenza virus hemagglutinin, MAb 3.1 demonstrates that de novo in silico-designed and affinity-matured synthetic proteins can foretell naturally selected antibody binding. This knowledge will aid development of a pan-influenza virus vaccine.</AbstractText>
<CopyrightInformation>Copyright © 2014, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wyrzucki</LastName>
<ForeName>Arkadiusz</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dreyfus</LastName>
<ForeName>Cyrille</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kohler</LastName>
<ForeName>Ines</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Steck</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wilson</LastName>
<ForeName>Ian A</ForeName>
<Initials>IA</Initials>
<AffiliationInfo><Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA hangartner.lars@virology.uzh.ch wilson@scripps.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hangartner</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Virology, University of Zurich, Zürich, Switzerland hangartner.lars@virology.uzh.ch wilson@scripps.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R56 AI099275</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>04</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000939">Epitopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019267">Hemagglutinin Glycoproteins, Influenza Virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007143">Immunoglobulin Heavy Chains</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017124" MajorTopicYN="N">Conserved Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019267" MajorTopicYN="N">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007143" MajorTopicYN="N">Immunoglobulin Heavy Chains</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053121" MajorTopicYN="N">Influenza A Virus, H2N2 Subtype</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24719426</ArticleId>
<ArticleId IdType="pii">JVI.00178-14</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.00178-14</ArticleId>
<ArticleId IdType="pmc">PMC4054347</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>PLoS One. 2012;7(4):e34415</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22496802</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):445-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24335589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20383002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1982 Dec;31(2 Pt 1):417-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6186384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2011 Aug 12;333(6044):850-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21798894</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2012 Mar 23;335(6075):1463</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22362880</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2008;3(12):e3942</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19079604</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20057044</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1983 Aug 19;221(4612):709-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6879170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Nov;85(21):11048-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21865387</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17040-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23027945</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2013;9(10):e1003657</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24130481</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2004 Mar 19;303(5665):1866-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14764887</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 1994 May 20;238(5):777-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8182748</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2007 Apr;7(4):267-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17363960</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):264-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23175789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2014 Feb;20(2):143-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24412922</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Immunol. 2008 Aug;45(14):3832-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18614234</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2012 Sep 14;337(6100):1343-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22878502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Biotechnol. 2012 Jun;30(6):543-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22634563</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1993 May;67(5):2552-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7682624</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2011 Feb;92(Pt 2):326-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21068214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 Feb;84(4):1715-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20007271</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2001 Oct;82(Pt 10):2475-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11562540</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Struct Mol Biol. 2013 Mar;20(3):363-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23396351</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 1987 Sep 20;197(2):273-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3681996</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Apr 10;324(5924):246-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19251591</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15299926</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Dec;10(12):2196-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15663860</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):32-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17164524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2005 Nov;43(11):5760-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16272514</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21825125</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2012 Sep 27;489(7417):526-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22982990</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Virol. 2001 Dec;146(12):2275-89</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11811679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Nov;87(22):12471-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24027321</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Struct Mol Biol. 2009 Mar;16(3):265-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19234466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 2012 Nov;250(1):180-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23046130</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2011 May 13;332(6031):816-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21566186</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):5986-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18413603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2013 Dec 6;342(6163):1230-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24311689</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2012 Sep 27;489(7417):566-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22932267</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10801978</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22371588</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Protoc. 2009;4(3):372-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19247287</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2013 Jul 12;341(6142):183-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23704376</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2013 Jan 20;435(2):320-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23084424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Jun;87(12):7149-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23552413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2011 Aug 12;333(6044):843-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21737702</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Canton de Zurich</li>
</region>
<settlement><li>Zurich</li>
</settlement>
<orgName><li>Université de Zurich</li>
</orgName>
</list>
<tree><country name="Suisse"><region name="Canton de Zurich"><name sortKey="Wyrzucki, Arkadiusz" sort="Wyrzucki, Arkadiusz" uniqKey="Wyrzucki A" first="Arkadiusz" last="Wyrzucki">Arkadiusz Wyrzucki</name>
</region>
<name sortKey="Hangartner, Lars" sort="Hangartner, Lars" uniqKey="Hangartner L" first="Lars" last="Hangartner">Lars Hangartner</name>
<name sortKey="Kohler, Ines" sort="Kohler, Ines" uniqKey="Kohler I" first="Ines" last="Kohler">Ines Kohler</name>
<name sortKey="Steck, Marco" sort="Steck, Marco" uniqKey="Steck M" first="Marco" last="Steck">Marco Steck</name>
<name sortKey="Wilson, Ian A" sort="Wilson, Ian A" uniqKey="Wilson I" first="Ian A" last="Wilson">Ian A. Wilson</name>
</country>
<country name="États-Unis"><region name="Californie"><name sortKey="Dreyfus, Cyrille" sort="Dreyfus, Cyrille" uniqKey="Dreyfus C" first="Cyrille" last="Dreyfus">Cyrille Dreyfus</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000100 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000100 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24719426
   |texte=   Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24719426" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2

Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.

Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki